Mobile health technologies for the management of rheumatic diseases: a systematic review of online stores in Brazil

• Published in: Clinical rheumatology 2021-07, Vol.40 (7), p.2601-2609
• Main Authors: Dantas, Lucas Ogura, Carvalho, Cristiano, Prando, Beatriz Cardinal, McAlindon, Timothy E., da Silva Serrão, Paula Regina Mendes
• Format: Article
• Language: English
• Subjects: Disease management; Fibromyalgia; Lupus; Medicine; Medicine & Public Health; Osteoarthritis; Osteoporosis; Review Article; Rheumatic diseases; Rheumatoid arthritis; Rheumatology; Systematic review; Systemic lupus erythematosus
• ISSN: 0770-3198; 1434-9949
• DOI: 10.1007/s10067-020-05561-y

Rheumatic diseases are serious conditions with a low uptake of conservative treatments. Mobile health (mHealth) applications (apps) offer potential to assist the self-management of rheumatic diseases. Our goal was to perform a systematic review of available mHealth apps for rheumatic diseases in Brazil. We focused on the most prevalent rheumatic diseases: osteoarthritis, rheumatoid arthritis, fibromyalgia, systemic lupus erythematosus, osteoporosis, and axial spondylarthritis. Google Play Store and AppStore in Brazil were queried by two independent reviewers on September 2020, and the quality of eligible mHealth apps was assessed using the Mobile App Rating Scale (MARS). Of the 3173 mHealth apps found, five were eligible for inclusion. Two for fibromyalgia and two for axial spondylarthritis offered exercise, educational content, and tools to track patient-reported symptoms; and one for osteoporosis offered educational content and tracking tools only. The included apps scored moderately on the MARS quality scale, with a mean score (SD) of 3.1 (0.7) on a 0–5 scale. Most apps scored poorly based on credibility, user interface and experience, and engagement. There is growing interest in the development of mHealth technologies to support rheumatic diseases patients. Although the majority of the included apps came from non-profit organizations, they are still of poor quality and limited functionality. This study is a call for to the development of new user-centered mHealth apps that can empower rheumatic diseases patients in Brazil, especially in the area of osteoarthritis, rheumatoid arthritis, and lupus, since no apps were found.